← Open Payments lookup

JENNIFER CRAYNER-ARYEE: Open Payments

NPI 1396166237 · VERONA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,165 in 56 payments from 11 companies in 2025. Trend: 2023 $163 · 2024 $665 · 2025 $1,165

Food & beverage: $944Education: $221
CompanyPaymentsAmount
Astellas Pharma US Inc8$315
United Therapeutics Corporation10$169
AstraZeneca Pharmaceuticals LP8$141
Merck Sharp & Dohme LLC8$139
GlaxoSmithKline, LLC.6$129
Actelion Pharmaceuticals US, Inc.5$83
Viatris Specialty LLC3$61
Boehringer Ingelheim Pharmaceuticals, Inc.3$51
Bayer Healthcare Pharmaceuticals Inc.3$46
Invivyd Inc1$18

Products named: WINREVAIR, TRELEGY ELLIPTA, Cresemba, Tyvaso, FASENRA, UPTRAVI, YUPELRI, TEZSPIRE.

Industry payments across NJ — which companies pay providers there.